1Lorsordo DW,Vale PR,Symes JF,et al.Gene therapy for myocardial angiogenesis,initial clinical results with direct myocardial injection of VEGF165 as sol-e therapy for myocardial ischemia[J].Circulation,1998,98(9):2800-2804.
2Rosengart TK,Lee LY,Patel SR,et al. Six-month assessment of a phase trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus expressing the VEGF121 cDNA[J]. Ann Surg,1999,23
3Sun Y, Jin K, Xie L,et,al. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia[J]. J Clin Invest,2003,111(12):1843-1851.
4Sonstein GR,Zaleski Y. Vascular endothelial growth factor expression in VAM[J].Neurosci Lett,2002,245(2):34-37.
5Hayashi T,Abe K,Suzuki H,et al. Rapid induction of vascular endothelial growth factor gene expression after transient middle cerebral artery occlusion in rats[J].Stroke,1997,2(10):2039-2044.
7Schumacher S, Peter P,Specht BU, et al. Indution of neoangiogenesis in isch-mic myocardium by human growth factors[J].Circulation,1998,97(11):645-650.
1Li XM,Tang ZY,Zhou G,et al. Significance of vascular endothelial growth factor mRNA expression in invasion and metastasis of hepatocellular carcinoma. J Exp Clin Cancer Res,1998,17(5) :13-17.
2Adachi E,Metsumata T,Nishizaki T,et al. Effects of preoperative hepatic artery chemoembolization for hepatocellular carcinoma.The relationship between postoperative course and tumor necrosis. Cancer,1993,72(9) :3593-3598.
3Kobayashi N,Ishii M,Ueno Y,et al. Co-expression of bcl-2 protein and vascular endothelial growth factor in hepatocellular carcinomas treated by chemombolization. Liver, 1999,19(1) : 25-31.
4Kunio S,Norio H, Yasuhide M,et al. Expression of vascular permeability/Vascular Endotheial Growth Factor in human hepatocellular carcinoma. Cancer Res, 1996,56(12) : 3004-3009.
5Baccala A, Zhong H, Cliff SM, et al. Serum vascular endothelial growth factor is a candidate biomarker of metastati tumor response of renal cell cancer. Urology,1998,51(10):327-332.
6Jin-no K, Tanimizu M, Hyodo I, et al. Circulating vascular endothelial growth factor is a possible tumor marker for metastasis in human hepatocellular carcinoma. J Gastroenterol,1998,33(5) :376-382.
7Nagasue N,Galizia G,Kohno H.et al. Adverse effects of preoperative hepatic artery chemoembolization for resectable hepatocellular carcinoma aretrospective comparision of 138 liver resection.Surgery, 1998,106(2) :81-86.
8Minchenko A,Bauer T, Salceda S, et al. Hypoxic stimulation of vascular endothelial growth factor expression in vitro and vivo.Lab Invest,1994,71(5) :374-379.
9Gao Y.Therapeutic potentials of angiostatin in the treatment of cancer.Haematologica,1999,84(7):643-650
10Plate KH,Breier G,Weich HA,et al.Vascular endothelial growth factor is a potential tumor angiogensis factor in human gliomas in vivo.Nature,1992,359(6398):845-848
8Wu Z, Wang S, Sorenson CM, etal. Attenuation of retinal vascular developmentand neovascularization in transgenic mice over-expressing thrombospondin-1 in thelens. Dev Dyn 2006 ;235 (7) : 1908-1920.
9Uno K, Bhutto IA, McLeod DS, et al. Impaired expression ofthrombospondin-1 ineyes with age related macular degeneration.Br J Ophthalmol 2006 ;90 ( 1 ) :48-54.
